CURRENT ISSUE Current Issue Cover
VOL 5 NO 2 • MAR/APR 2014
IN THIS ISSUE

Celebrities and Medicine: A Potent Combination

Pamela Hallquist Viale, RN, MS, CNS, ANP

The Launch of the Advanced Practitioner Society for Hematology and Oncology (APSHO)

Pamela Hallquist Viale, RN, MS, CNS, ANP, Christopher J. Campen, PharmD, BCPS, BCOP, Sandra E. Kurtin, RN, MS, AOCN®, ANP-C, and Wendy H. Vogel, MSN, FNP, AOCNP®

Leaders of ASCO, ASH, ASTRO, and NCCN Embrace Collaboration With Advanced Practitioners

Susan Reckling

Advanced Practitioners in Oncology: Diverse Experiences, Shared Challenges

Susan Reckling

More Articles More Articles
 
Section Seperator

TODAY'S NEWS

FDA Approves First HPV Test for Primary ...

The U.S. Food and Drug Administration today approv...

Human Papillomavirus Vaccine Proves Effe...

A study of HIV-infected women in the United States...

FDA Proposes to Extend Its Tobacco Autho...

As part of its implementation of the Family Smokin...

Doxepin Rinse Reduces Radiotherapy-Assoc...

In a phase III double-blind crossover trial report...

Ado-Trastuzumab Emtansine Plus Pertuzuma...

In a phase IIa trial reported in the <em>Jou...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Improving Surgical Outcomes in Pancreatic Surgery

Pancreatic cancer is the fourth leading cause of cancer-associated death...

Distress Screening in Chronic Disease

Distress is a psychological state that is often observed in patients with chronic disease...

Information Needs Priorities in Patients Diagnosed

Research studies on information needs...

Calculating Your Worth

While health-care dollars shrink and the focus on delivering more care with less grows...

Ado-Trastuzumab Emtansine in Metastatic HER2

Breast cancer is the most common cancer in US women...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

FDA Approves Siltuximab for Rare Castlem...

The U.S. Food and Drug Administration (FDA) today ...

Study Shows Decreasing Numbers of Colore...

Nationwide data on mortality and morbidity from co...

FDA Grants Orphan Drug Designation to Al...

The U.S. Food and Drug Administration has granted ...

Experimental Drug Receives Fast Track De...

OncoGenex Pharmaceuticals, Inc, today announced th...

Adding Everolimus to Trastuzumab/Vinorel...

In the double-blind phase III BOLERO-3 trial repor...

More Highlights More Highlights
 
Section Seperator
Section Seperator
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer